IMCR 8-K: SEC filing
Filed with the SEC on · accession 0001671927-26-000034
IMCR filed a 8-K (current report) with the SEC on Nov 6, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved +4.9% by the first close after the filing.
Summary of the filing
Immunocore Holdings plc furnished an 8-K reporting its financial results for the third quarter ended September 30, 2026, along with recent corporate updates, via a press release attached as Exhibit 99.1.
Key details
How IMCR stock reacted
Close before
$28.40
Nov 5, 2026
First close after
+4.88%
$29.79
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for IMCR, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for IMCR?
Click hereFrequently asked questions
What did IMCR file with the SEC on Nov 6, 2026?
IMCR filed a 8-K (SEC filing). Immunocore Holdings plc furnished an 8-K reporting its financial results for the third quarter ended September 30, 2026, along with recent corporate updates, via a press release attached as Exhibit 99.1.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
How did IMCR stock react to this filing?
IMCR closed at $28.40 before the filing and $29.79 on Nov 6, 2026 (+4.88%).
Other IMCR SEC filings
Get alerts when IMCR files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days